MILLS KENNETH T. (President and CEO) exercised options at REGENXBIO INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 1/29/2026ACC: 0001652824-26-000002
DirectorOfficer· President and CEO
Since Aug 2018
-221.75K
Net shares
Net seller
$2.97M
Total sold
0
Open market trades
0B · 0S
3
Total transactions
225K acquired · 446.75K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+225K
Price / share
$13.09
Trade value
$2.95M
% of position
46.6%
1/27/2026
482.87K→707.87K
Common Stock
Direct
Shares
−221.75K
Price / share
$13.41
Trade value
$2.97M
% of position
31.3%
1/27/2026
707.87K→486.12K
Total
Net shares
+3.25K
Net value
-$28.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/27/2026 | M · Option Exercise | +225K | $13.09 | $2.95M | 46.6% | 482.87K | 707.87K |
| Common Stock Direct | 1/27/2026 | F · Tax Withholding | −221.75K | $13.41 | $2.97M | 31.3% | 707.87K | 486.12K |
| Total | +3.25K | -$28.46K | ||||||
Derivative Transactions1
Stock Options (Right to Buy)
Direct
Converts to
Common Stock
225K shares
Shares
−225K
Strike price
13.09
Held after
225K
Exercisable
—
1/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock225K shares | 1/27/2026 | M · Option Exercise | −225K | 13.09 | — | 225K |